APO RESEARCH · REPORT
2,3-Bornanedione
2,3-Bornanedione is a carbonyl-containing chemical substance identified by its named structure.
Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 2,3-Bornanedione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 2,3-Bornanedione?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 2,3-Bornanedione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Industry Growth & Trends
Global 2,3-Bornanedione Industry Growth and Trends Forecast to 2032
Market perspective
The global 2,3-Bornanedione market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for 2,3-Bornanedione is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for 2,3-Bornanedione is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 2,3-Bornanedione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 2,3-Bornanedione include Yuanshu Pharmaceutical Technology, Haihang Group, Warshel Chemical, Starsky International Holdings, Shiv Shakti Pharma Chem, Sarex and Resins and Allied Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global 2,3-Bornanedione market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The 2,3-Bornanedione market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 2,3-Bornanedione market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 2,3-Bornanedione.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global 2,3-Bornanedione market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
2,3-Bornanedione Market by Company
Yuanshu Pharmaceutical Technology
Haihang Group
Warshel Chemical
Starsky International Holdings
Shiv Shakti Pharma Chem
Sarex
Resins and Allied Products
2,3-Bornanedione Segment by Type
Purity ≥98%
Purity ≥99%
Others
2,3-Bornanedione Segment by Application
Dentistry
Electronics Industry
Others
2,3-Bornanedione Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 2,3-Bornanedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 2,3-Bornanedione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 2,3-Bornanedione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 2,3-Bornanedione manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of 2,3-Bornanedione in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98%
- Purity ≥99%
- Others
Applications
- Dentistry
- Electronics Industry
- Others
Companies covered
- Yuanshu Pharmaceutical Technology
- Haihang Group
- Warshel Chemical
- Starsky International Holdings
- Shiv Shakti Pharma Chem
- Sarex
- Resins and Allied Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 2,3-Bornanedione Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global 2,3-Bornanedione Sales Estimates and Forecasts (2021-2032)
- 1.3 2,3-Bornanedione Market by Type
- 1.3.1 Purity ≥98%
- 1.3.2 Purity ≥99%
- 1.3.3 Others
- 1.4 Global 2,3-Bornanedione Market Size by Type
- 1.4.1 Global 2,3-Bornanedione Market Size Overview by Type (2021-2032)
- 1.4.2 Global 2,3-Bornanedione Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global 2,3-Bornanedione Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America 2,3-Bornanedione Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe 2,3-Bornanedione Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific 2,3-Bornanedione Sales Breakdown by Type (2021-2026)
- 1.5.4 South America 2,3-Bornanedione Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa 2,3-Bornanedione Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 2,3-Bornanedione Industry Trends
- 2.2 2,3-Bornanedione Industry Drivers
- 2.3 2,3-Bornanedione Industry Opportunities and Challenges
- 2.4 2,3-Bornanedione Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by 2,3-Bornanedione Revenue (2021-2026)
- 3.2 Global Top Players by 2,3-Bornanedione Sales (2021-2026)
- 3.3 Global Top Players by 2,3-Bornanedione Price (2021-2026)
- 3.4 Global 2,3-Bornanedione Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 2,3-Bornanedione Major Company Production Sites & Headquarters
- 3.6 Global 2,3-Bornanedione Company, Product Type & Application
- 3.7 Global 2,3-Bornanedione Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 2,3-Bornanedione Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 2,3-Bornanedione Players Market Share by Revenue in 2025
- 3.8.3 2025 2,3-Bornanedione Tier 1, Tier 2, and Tier 3
4 2,3-Bornanedione Regional Status and Outlook
- 4.1 Global 2,3-Bornanedione Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global 2,3-Bornanedione Historic Market Size by Region
- 4.2.1 Global 2,3-Bornanedione Sales in Volume by Region (2021-2026)
- 4.2.2 Global 2,3-Bornanedione Sales in Value by Region (2021-2026)
- 4.2.3 Global 2,3-Bornanedione Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global 2,3-Bornanedione Forecasted Market Size by Region
- 4.3.1 Global 2,3-Bornanedione Sales in Volume by Region (2027-2032)
- 4.3.2 Global 2,3-Bornanedione Sales in Value by Region (2027-2032)
- 4.3.3 Global 2,3-Bornanedione Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 2,3-Bornanedione by Application
- 5.1 2,3-Bornanedione Market by Application
- 5.1.1 Dentistry
- 5.1.2 Electronics Industry
- 5.1.3 Others
- 5.2 Global 2,3-Bornanedione Market Size by Application
- 5.2.1 Global 2,3-Bornanedione Market Size Overview by Application (2021-2032)
- 5.2.2 Global 2,3-Bornanedione Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global 2,3-Bornanedione Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America 2,3-Bornanedione Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe 2,3-Bornanedione Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific 2,3-Bornanedione Sales Breakdown by Application (2021-2026)
- 5.3.4 South America 2,3-Bornanedione Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa 2,3-Bornanedione Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yuanshu Pharmaceutical Technology
- 6.1.1 Yuanshu Pharmaceutical Technology Company Information
- 6.1.2 Yuanshu Pharmaceutical Technology Business Overview
- 6.1.3 Yuanshu Pharmaceutical Technology 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yuanshu Pharmaceutical Technology 2,3-Bornanedione Product Portfolio
- 6.1.5 Yuanshu Pharmaceutical Technology Recent Developments
- 6.2 Haihang Group
- 6.2.1 Haihang Group Company Information
- 6.2.2 Haihang Group Business Overview
- 6.2.3 Haihang Group 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Haihang Group 2,3-Bornanedione Product Portfolio
- 6.2.5 Haihang Group Recent Developments
- 6.3 Warshel Chemical
- 6.3.1 Warshel Chemical Company Information
- 6.3.2 Warshel Chemical Business Overview
- 6.3.3 Warshel Chemical 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Warshel Chemical 2,3-Bornanedione Product Portfolio
- 6.3.5 Warshel Chemical Recent Developments
- 6.4 Starsky International Holdings
- 6.4.1 Starsky International Holdings Company Information
- 6.4.2 Starsky International Holdings Business Overview
- 6.4.3 Starsky International Holdings 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Starsky International Holdings 2,3-Bornanedione Product Portfolio
- 6.4.5 Starsky International Holdings Recent Developments
- 6.5 Shiv Shakti Pharma Chem
- 6.5.1 Shiv Shakti Pharma Chem Company Information
- 6.5.2 Shiv Shakti Pharma Chem Business Overview
- 6.5.3 Shiv Shakti Pharma Chem 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Shiv Shakti Pharma Chem 2,3-Bornanedione Product Portfolio
- 6.5.5 Shiv Shakti Pharma Chem Recent Developments
- 6.6 Sarex
- 6.6.1 Sarex Company Information
- 6.6.2 Sarex Business Overview
- 6.6.3 Sarex 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sarex 2,3-Bornanedione Product Portfolio
- 6.6.5 Sarex Recent Developments
- 6.7 Resins and Allied Products
- 6.7.1 Resins and Allied Products Company Information
- 6.7.2 Resins and Allied Products Business Overview
- 6.7.3 Resins and Allied Products 2,3-Bornanedione Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Resins and Allied Products 2,3-Bornanedione Product Portfolio
- 6.7.5 Resins and Allied Products Recent Developments
7 North America by Country
- 7.1 North America 2,3-Bornanedione Sales by Country
- 7.1.1 North America 2,3-Bornanedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America 2,3-Bornanedione Sales by Country (2021-2026)
- 7.1.3 North America 2,3-Bornanedione Sales Forecast by Country (2027-2032)
- 7.2 North America 2,3-Bornanedione Market Size by Country
- 7.2.1 North America 2,3-Bornanedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America 2,3-Bornanedione Market Size by Country (2021-2026)
- 7.2.3 North America 2,3-Bornanedione Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe 2,3-Bornanedione Sales by Country
- 8.1.1 Europe 2,3-Bornanedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe 2,3-Bornanedione Sales by Country (2021-2026)
- 8.1.3 Europe 2,3-Bornanedione Sales Forecast by Country (2027-2032)
- 8.2 Europe 2,3-Bornanedione Market Size by Country
- 8.2.1 Europe 2,3-Bornanedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe 2,3-Bornanedione Market Size by Country (2021-2026)
- 8.2.3 Europe 2,3-Bornanedione Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific 2,3-Bornanedione Sales by Country
- 9.1.1 Asia-Pacific 2,3-Bornanedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific 2,3-Bornanedione Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific 2,3-Bornanedione Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific 2,3-Bornanedione Market Size by Country
- 9.2.1 Asia-Pacific 2,3-Bornanedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific 2,3-Bornanedione Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific 2,3-Bornanedione Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America 2,3-Bornanedione Sales by Country
- 10.1.1 South America 2,3-Bornanedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America 2,3-Bornanedione Sales by Country (2021-2026)
- 10.1.3 South America 2,3-Bornanedione Sales Forecast by Country (2027-2032)
- 10.2 South America 2,3-Bornanedione Market Size by Country
- 10.2.1 South America 2,3-Bornanedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America 2,3-Bornanedione Market Size by Country (2021-2026)
- 10.2.3 South America 2,3-Bornanedione Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa 2,3-Bornanedione Sales by Country
- 11.1.1 Middle East and Africa 2,3-Bornanedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa 2,3-Bornanedione Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa 2,3-Bornanedione Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa 2,3-Bornanedione Market Size by Country
- 11.2.1 Middle East and Africa 2,3-Bornanedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa 2,3-Bornanedione Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa 2,3-Bornanedione Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 2,3-Bornanedione Value Chain Analysis
- 12.1.1 2,3-Bornanedione Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 2,3-Bornanedione Production Mode & Process
- 12.2 2,3-Bornanedione Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 2,3-Bornanedione Distributors
- 12.2.3 2,3-Bornanedione Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst